6523.T
PHC Holdings Corporation [6523.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
6523.T Stock Summary
In the News
6523.T Financial details
Company Rating
Strong Buy
Market Cap
188.61B
Income
-6.87B
Revenue
352.67B
Book val./share
1172.27
Cash/share
504.12
Dividend
72
Dividend %
4.81%
Employees
9.4K
Optionable
No
Shortable
Yes
Earnings
10 Feb 2024
P/E
-27.4
Forward P/E
12.35
PEG
12.16
P/S
0.53
P/B
1.28
P/C
2.96
P/FCF
7.3
Quick Ratio
0.95
Current Ratio
1.44
Debt / Equity
1.96
LT Debt / Equity
1.77
-
-
EPS (TTM)
-54.83
EPS next Y
120.95
EPS next Q
39.01
EPS this Y
-63.51%
EPS next Y
-320.59%
EPS next 5Y
-404.05%
EPS last 5Y
NAN%
Revenue last 5Y
13.83%
Revenue Q/Q
5.13%
EPS Q/Q
-123.19%
-
-
-
-
SMA20
2.06%
SMA50
-4.29%
SMA100
-5.17%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-5%
ROC
0.03%
Gross Margin
46%
Oper. Margin
4%
Profit Margin
-2%
Payout
-131%
Shs Outstand
125.91M
Shs Float
25.92M
-
-
-
-
Target Price
-
52W Range
1362.0-1688.0
52W High
-11.49%
52W Low
+9.69%
RSI
56.74
Rel Volume
0.56
Avg Volume
263.06K
Volume
147.3K
Perf Week
4.33%
Perf Month
2.4%
Perf Quarter
0.74%
Perf Half Y
-8.17%
-
-
-
-
Beta
0.939
-
-
Volatility
31.55%, 33.66%
Prev Close
0.81%
Price
1494
Change
1.29%
6523.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.57K | 2.3K | 2.7K | 2.85K | 2.86K | |
| Net income per share | 130.11 | 44.43 | 149.06 | -70.78 | -25.83 | |
| Operating cash flow per share | 284.51 | 310.4 | 421.9 | 427.12 | 171.44 | |
| Free cash flow per share | 227.54 | 203.19 | 314.74 | 328.94 | 79.08 | |
| Cash per share | 433.76 | 422.6 | 563.98 | 816.75 | 507.31 | |
| Book value per share | 549.51 | 591.72 | 943.6 | 1.13K | 1.11K | |
| Tangible book value per share | -1.05K | -2.07K | -1.82K | -1.35K | -1.22K | |
| Share holders equity per share | 549.51 | 591.72 | 943.6 | 1.13K | 1.11K | |
| Interest debt per share | 1.59K | 2.89K | 2.93K | 2.64K | 2.51K | |
| Market cap | 314.85B | 314.85B | 300.66B | 216.11B | 178.55B | |
| Enterprise value | 451.65B | 604.49B | 561.45B | 428.81B | 410.23B | |
| P/E ratio | 20.37 | 59.66 | 17.78 | -25.54 | -55.43 | |
| Price to sales ratio | 1.69 | 1.15 | 0.98 | 0.63 | 0.5 | |
| POCF ratio | 9.32 | 8.54 | 6.28 | 4.23 | 8.35 | |
| PFCF ratio | 11.65 | 13.05 | 8.42 | 5.5 | 18.11 | |
| P/B Ratio | 4.82 | 4.48 | 2.81 | 1.6 | 1.29 | |
| PTB ratio | 4.82 | 4.48 | 2.81 | 1.6 | 1.29 | |
| EV to sales | 2.42 | 2.22 | 1.83 | 1.26 | 1.15 | |
| Enterprise value over EBITDA | 11.55 | 15.02 | 8.73 | 10.31 | 8.3 | |
| EV to operating cash flow | 13.37 | 16.4 | 11.73 | 8.4 | 19.19 | |
| EV to free cash flow | 16.71 | 25.05 | 15.73 | 10.91 | 41.61 | |
| Earnings yield | 0.05 | 0.02 | 0.06 | -0.04 | -0.02 | |
| Free cash flow yield | 0.09 | 0.08 | 0.12 | 0.18 | 0.06 | |
| Debt to equity | 2.86 | 4.77 | 3 | 2.27 | 2.12 | |
| Debt to assets | 0.57 | 0.63 | 0.57 | 0.52 | 0.52 | |
| Net debt to EBITDA | 3.5 | 7.19 | 4.06 | 5.11 | 4.69 | |
| Current ratio | 1.47 | 1.25 | 0.4 | 1.57 | 1.52 | |
| Interest coverage | 9.89 | 1.7 | 1.58 | 1.09 | 0.99 | |
| Income quality | 1.64 | 6.57 | 2.1 | 17.01 | 119.42 | |
| Dividend Yield | 0 | 0.47 | 0.02 | 1.41 | 0.05 | |
| Payout ratio | 0.09 | 28.33 | 0.32 | -36.07 | -2.86 | |
| Sales general and administrative to revenue | 0.51 | 0.45 | 0.42 | 0.42 | 0.39 | |
| Research and developement to revenue | 0 | 0 | 0 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.59 | 0.6 | 0.55 | 0.5 | 0.52 | |
| Capex to operating cash flow | -0.2 | -0.35 | -0.25 | -0.23 | -0.54 | |
| Capex to revenue | -0.04 | -0.05 | -0.04 | -0.03 | -0.03 | |
| Capex to depreciation | -0.42 | -0.47 | -0.4 | -0.38 | -0.4 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.27K | 769.13 | 1.78K | 1.34K | 802.09 | |
| ROIC | 0.07 | 0.03 | 0.03 | -0.05 | -0.79 | |
| Return on tangible assets | 0.11 | 0.02 | 0.07 | -0.03 | -0.01 | |
| Graham Net | -1.46K | -2.96K | -2.91K | -2.41K | -2.26K | |
| Working capital | 35.02B | 28.74B | -253.63B | 78.62B | 67.74B | |
| Tangible asset value | -125.07B | -246.03B | -206.33B | -160.83B | -152B | |
| Net current asset value | -150.76B | -315.08B | -289.1B | -238.9B | -225.16B | |
| Invested capital | 2.86 | 4.77 | 3 | 2.27 | 2.12 | |
| Average receivables | 0 | 44.13B | 59.4B | 64.06B | 66.5B | |
| Average payables | 0 | 50.07B | 64.11B | 69.08B | 67.22B | |
| Average inventory | 0 | 27.36B | 36.72B | 41.67B | 48.12B | |
| Days sales outstanding | 66.25 | 72.82 | 76.8 | 68.32 | 70.94 | |
| Days payables outstanding | 217.7 | 159.11 | 155.86 | 143.33 | 127.91 | |
| Days of inventory on hand | 106.06 | 93.55 | 87.26 | 92.72 | 100.81 | |
| Receivables turnover | 5.51 | 5.01 | 4.75 | 5.34 | 5.14 | |
| Payables turnover | 1.68 | 2.29 | 2.34 | 2.55 | 2.85 | |
| Inventory turnover | 3.44 | 3.9 | 4.18 | 3.94 | 3.62 | |
| ROE | 0.24 | 0.08 | 0.16 | -0.06 | -0.02 | |
| Capex per share | -56.97 | -107.21 | -107.16 | -98.19 | -92.36 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 714.62 | 757.14 | 729.93 | 647.99 | 680.03 | |
| Net income per share | 66.6 | 17.69 | -52.94 | -25.49 | 5.9 | |
| Operating cash flow per share | 28.41 | 11.22 | 116.04 | 65.51 | 114.98 | |
| Free cash flow per share | 9.95 | -2.95 | 83.52 | 35.05 | 90.34 | |
| Cash per share | 611.21 | 500.51 | 505.53 | 455.22 | 504.12 | |
| Book value per share | 1.19K | 1.11K | 1.1K | 1.15K | 1.17K | |
| Tangible book value per share | -1.32K | -1.28K | -1.21K | -1.29K | -1.25K | |
| Share holders equity per share | 1.19K | 1.11K | 1.1K | 1.15K | 1.17K | |
| Interest debt per share | 2.5K | 2.43K | 2.39K | 2.4K | 2.31K | |
| Market cap | 178.26B | 183.88B | 179.18B | 193.4B | 191.85B | |
| Enterprise value | 414.17B | 420.86B | 410.86B | 434.6B | 419.41B | |
| P/E ratio | 5.37 | 20.82 | -6.76 | -15.11 | 64.64 | |
| Price to sales ratio | 2 | 1.95 | 1.96 | 2.38 | 2.24 | |
| POCF ratio | 50.34 | 131.25 | 12.34 | 23.52 | 13.27 | |
| PFCF ratio | 143.76 | -499.68 | 17.15 | 43.96 | 16.89 | |
| P/B Ratio | 1.2 | 1.33 | 1.3 | 1.34 | 1.3 | |
| PTB ratio | 1.2 | 1.33 | 1.3 | 1.34 | 1.3 | |
| EV to sales | 4.65 | 4.45 | 4.5 | 5.34 | 4.91 | |
| Enterprise value over EBITDA | 21.47 | 22.92 | 73.39 | 49.87 | 45.04 | |
| EV to operating cash flow | 116.96 | 300.4 | 28.3 | 52.86 | 29.02 | |
| EV to free cash flow | 334.01 | -1.14K | 39.32 | 98.8 | 36.93 | |
| Earnings yield | 0.05 | 0.01 | -0.04 | -0.02 | 0 | |
| Free cash flow yield | 0.01 | 0 | 0.06 | 0.02 | 0.06 | |
| Debt to equity | 2.09 | 2.15 | 2.12 | 2.05 | 1.96 | |
| Debt to assets | 0.52 | 0.52 | 0.52 | 0.52 | 0.51 | |
| Net debt to EBITDA | 12.23 | 12.9 | 41.39 | 27.68 | 24.44 | |
| Current ratio | 1.53 | 1.51 | 1.52 | 1.48 | 1.44 | |
| Interest coverage | 3.8 | 1.58 | -0.24 | 0.3 | 1.22 | |
| Income quality | 0.37 | 0.35 | -2.01 | -2.29 | 25.91 | |
| Dividend Yield | 0 | 0.02 | 0 | 0.02 | 0 | |
| Payout ratio | 0.06 | 1.9 | -0.05 | -1.31 | 0.45 | |
| Sales general and administrative to revenue | 0.38 | 0.37 | 0.38 | 0.44 | 0.42 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.53 | 0.52 | 0.52 | 0.53 | 0.53 | |
| Capex to operating cash flow | -0.65 | -1.26 | -0.28 | -0.46 | -0.21 | |
| Capex to revenue | -0.03 | -0.02 | -0.04 | -0.05 | -0.04 | |
| Capex to depreciation | -0.31 | -0.24 | -0.6 | -0.57 | -0.46 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.34K | 663.15 | 1.15K | 811.22 | 394.55 | |
| ROIC | 0.02 | 0.01 | 0 | 0 | 0.01 | |
| Return on tangible assets | 0.03 | 0.01 | -0.02 | -0.01 | 0 | |
| Graham Net | -2.39K | -2.33K | -2.25K | -2.33K | -2.25K | |
| Working capital | 70.63B | 66.47B | 67.74B | 63.48B | 59.44B | |
| Tangible asset value | -165.11B | -159.51B | -152B | -161.51B | -157.37B | |
| Net current asset value | -244B | -233.74B | -225.16B | -233.85B | -229.72B | |
| Invested capital | 2.09 | 2.15 | 2.12 | 2.05 | 1.96 | |
| Average receivables | 61.74B | 65.54B | 68.89B | 67.72B | 64.91B | |
| Average payables | 65.25B | 65.99B | 66.39B | 64.7B | 64.52B | |
| Average inventory | 50.39B | 52.31B | 52.14B | 55.01B | 58.37B | |
| Days sales outstanding | 63.24 | 65.22 | 68.27 | 73.21 | 67.03 | |
| Days payables outstanding | 126.3 | 124.25 | 120.33 | 130.64 | 122.92 | |
| Days of inventory on hand | 101.39 | 97.26 | 94.83 | 119.41 | 110.08 | |
| Receivables turnover | 1.42 | 1.38 | 1.32 | 1.23 | 1.34 | |
| Payables turnover | 0.71 | 0.72 | 0.75 | 0.69 | 0.73 | |
| Inventory turnover | 0.89 | 0.93 | 0.95 | 0.75 | 0.82 | |
| ROE | 0.06 | 0.02 | -0.05 | -0.02 | 0.01 | |
| Capex per share | -18.46 | -14.17 | -32.53 | -30.46 | -24.64 |
6523.T Frequently Asked Questions
What is PHC Holdings Corporation stock symbol ?
PHC Holdings Corporation is a JP stock and trading under the symbol 6523.T
What is PHC Holdings Corporation stock quote today ?
PHC Holdings Corporation stock price is $1494 today.
Is PHC Holdings Corporation stock public?
Yes, PHC Holdings Corporation is a publicly traded company.
Company Profile
- Volume Average 263.06K
- Market Capitalization 188.61B
- Employee 9.4K
- CEO Mr. Shoji Miyazaki
- Headquarters Tokyo,JP
- IPO Date 2021-10-14
-
Website
https://www.phchd.com/jp 
PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.
